With more than 90% of revenue coming from pharma and biotech companies outside the top 25, CRO SynteractHCR is seeing more growth stemming from an influx of funding to smaller biotech companies, CEO Wendel Barr told us on the third day of the 51st annual...
Growing demand has prompted tableting specialist Meldex
International, formerly BioProgress, to launch a new sales and
distribution hub in Germany, with the UK firm also announcing a new
manufacturing contract for its XGel film.
Just weeks after disappointing news regarding its potential
billion-dollar drug satraplatin was swiftly followed by a class
action lawsuit against the company, GPC Biotech has announced plans
to cut 15 per cent of its workforce.
A new market-oriented approach to product development, more
favourable licensing arrangements, strategic acquisitions and a
fresh crop of proprietary drug-delivery technologies helped UK
company BioProgress to deliver an adjusted...
UK firm SkyePharma has announced that it has finally completed the
sale of its deadweight injectable business, freeing up the company
to focus on the development of products that the company believes
could rival those of the pharma...